A recent study confirms lenacapavir's effectiveness against HIV and highlights the capsid as a promising drug target despite resistance.
A group of University of Chicago scientists announced a groundbreaking study that explores the role of a small molecule, called IP6, in building the HIV-1 virus capsid. The genetic information of the ...
Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the ...
A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated ...
In a recent study published in The Lancet Microbe journal, researchers described the effectiveness of a modular capsid virus-like coronavirus disease 2019 (COVID-19) vaccination. Study: First-in-human ...
The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it. More than 40 million people worldwide live with AIDS because of this virus, ...
University of Delaware researcher Juan Perilla is a computational scientist with the heart of a storyteller. But he doesn’t want to tell computer stories. He wants to tell stories about the life cycle ...
U.S. scientists have discovered a hidden molecular “switch” that herpes viruses rely on to invade cells. By combining AI, ...
Inside a cell, a single protein emerges from from the cell’s protein-making machinery, then another, and another. They move about—bouncing into one another, wriggling around, and drifting away again.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results